Breast Cancer Breakthroughs: SABCS 2025 Highlights
Experts in Dana-Farber’s Breast Oncology Center discuss highlights in breast cancer research innovation presented at SABCS 2025 in San Antonio, Texas, including what the data mean, how it can be used in clinic, and what’s next in the field of breast cancer research.
2025 San Antonio Breast Cancer Symposium Highlights
Harold Burstein, MD, PhD, and other breast cancer experts at Dana-Farber discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.
2025 SABCS Highlights: Targeted Therapies for Advanced Breast Cancer
Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the CAPItello-291, VIKTORIA-1, and STX-478 trials which were presented at the 2025 San Antonio Breast Cancer Symposium
2025 SABCS Highlights: Advances in ctDNA for Breast Cancer
Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in ctDNA and minimal residual disease (MRD) for breast cancer in the neoadjuvant, adjuvant, and advance settings. This research was presented at the 2025 San ...
2025 SABCS Highlights: Advances in ADC's for Advanced Breast Cancer
Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD, discuss the ASCENT-04, ASCENT-03, TROPION-Breast02, ASCENT-07, and OptiTROP-Breast02 trials researching antibody-drug conjugates (ADCs) for breast cancer.
2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for first-line treatment in advanced breast cancer, which were presented at the 2025 San Antonio Breast Cancer Symposium.
SABCS Highlights: Advances in Oral SERD's for Breast Cancer
Harold Burstein, MD, PhD, and Rinath M. Jeselsohn, MD, discuss the lidERA, evERA, and EMBER-3 trials researching oral selective estrogen receptor degraders (SERDs).
SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer
Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.
SABCS 2025 Highlights: Patient Perspective
Lindsay Northrop, breast cancer survivor and patient advocate at Dana-Farber, talks with Harold Burstein, MD, PhD, about how recent advances in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium will impact patient care.
2025 San Antonio Breast Cancer Symposium Recap
Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.
2025 San Antonio Breast Cancer Symposium Panel Discussion
Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and Elizabeth Ann Mittendorf, MD, PhD, MHCM, discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.
